Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-08-08

Clinical Trial Update: Clinical Trial of Gammora® Plus Antiretroviral Treatment for HIV [Phase 2]

View source ↗

Summary

Phase 2 clinical trial is evaluating Gammora Plus antiretroviral treatment for HIV and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Gammora Plus (Gammora Plus)

Snippet

Sponsor: Federal University of São Paulo | Conditions: HIV Seropositivity | Phase 2 | Status: RECRUITING